New drug - Toviaz
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
In all the doom and gloom of our chaotic NHS, it really is good once in a while to be able to report... Read more
Parkinson's third law says 'Growth leads to complexity, complexity to decay'. It couldn't describe t... Read more
The NHS is approaching its 60th birthday and Lord Darzi is about to publish his review, so I thought... Read more
One of the least-recognised attributes of a truly free market is that it contains a lot of informati... Read more
The economist Milton Friedman made a telling observation: the care with which we spend money depends... Read more
One of the less attractive aspects of the purchaser-provider split is the ham-fisted way in which pr... Read more
I was delighted to hear that NHS managers have been taken aback by the strength of feeling against t... Read more
Recently I asked who should be in ultimate charge of the NHS, and concluded that it works far more e... Read more
This government is undeniably underhand. Nothing is ever done for the reasons given; hidden agendas ... Read more
Yet again, GPs are to have our standards challenged - and raised. This time the Office of Health Eco... Read more
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more